| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 580,000 options to buy
@ $6.84, valued at
$4M
|
|
| 01/07/2022 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 500,000 options to buy
@ $14.55, valued at
$7.3M
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 38,461 shares
@ $2.6, valued at
$100k
|
|
| 01/13/2020 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.29, valued at
$658k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2019 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 2,000 shares
@ $4.655, valued at
$9.3k
|
|
| 08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 175,000 options to buy
@ $22.85, valued at
$4M
|
|
| 06/27/2018 |
4
| Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 88,967 options to buy
@ $5.91, valued at
$525.8k
|
|
| 06/20/2018 |
3
| Fowler John Franklin (CEO) has filed a Form 3 on Kezar Life Sciences, Inc. |